BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32394409)

  • 1. Involvement of ionic interactions in cytokine adsorption of polyethyleneimine-coated polyacrylonitrile and polymethyl methacrylate membranes in vitro.
    Moriyama K; Kato Y; Hasegawa D; Kurimoto Y; Kawaji T; Nakamura T; Kuriyama N; Shimomura Y; Nishida O
    J Artif Organs; 2020 Sep; 23(3):240-246. PubMed ID: 32394409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters.
    Hiraiwa T; Moriyama K; Matsumoto K; Shimomura Y; Kato Y; Yamashita C; Hara Y; Kawaji T; Kurimoto Y; Nakamura T; Kuriyama N; Shibata J; Komura H; Morita K; Nishida O
    Blood Purif; 2020; 49(3):295-301. PubMed ID: 31995801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cytokine adsorption ability in continuous renal replacement therapy using polyethyleneimine-coated polyacrylonitrile (AN69ST) or polymethylmethacrylate (PMMA) hemofilters: a pilot single-center open-label randomized control trial.
    Nakamura Y; Hatomoto H; Yamasaki S; Yamauchi K; Kiyomi F; Hoshino K; Kawano Y; Nakano T; Hasegawa T; Ishikura H
    Eur J Med Res; 2023 Jun; 28(1):208. PubMed ID: 37391846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyethyleneimine-treated polyacrylonitrile membrane hemofilter for critically ill patients receiving anticoagulant-free prolonged intermittent renal replacement therapy: a single-center, prospective, self-controlled pilot study.
    Su T; Jin Q; Liu Z
    BMC Nephrol; 2017 Jun; 18(1):208. PubMed ID: 28666474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of high mobility group box 1 protein removal with various membranes for continuous hemofiltration.
    Yumoto M; Nishida O; Moriyama K; Shimomura Y; Nakamura T; Kuriyama N; Hara Y; Yamada S
    Ther Apher Dial; 2011 Aug; 15(4):385-93. PubMed ID: 21884474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine filtration and adsorption during pre- and postdilution hemofiltration in four different membranes.
    Bouman CS; van Olden RW; Stoutenbeek CP
    Blood Purif; 1998; 16(5):261-8. PubMed ID: 9917534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analysis of factors affecting the continuous hemodiafiltration clearance of teicoplanin.
    Sawada M; Uchida M; Yamazaki S; Suzuki T; Suzuki T; Ishii I
    Artif Organs; 2023 Apr; 47(4):667-679. PubMed ID: 36310410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Proteins and Cells that Adsorb to Dialysis Membranes Used in Continuous Hemodiafiltration: Comparison of AN69ST, Polymethylmethacrylate, and Polysulfone Membranes.
    Michikoshi J; Matsumoto S; Miyawaki H; Morita M; Niu H; Seo K; Hagiwara S; Kitano T
    Blood Purif; 2019; 48(4):358-367. PubMed ID: 31344702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption as a Contributor for Inflammatory Mediators Removal by Different Hemofiltration Membranes: A Pilot Study.
    Malard B; Florens N; Lambert C; Juillard L
    Artif Organs; 2017 Jun; 41(6):545-555. PubMed ID: 27911005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Larger Membrane Area Increases Cytokine Removal in Polymethyl Methacrylate Hemofilters.
    Nakamura T; Moriyama K; Kuriyama N; Hara Y; Komatsu S; Kawaji T; Kato Y; Ishihara T; Shintani A; Nishida O
    Membranes (Basel); 2022 Aug; 12(8):. PubMed ID: 36005726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adsorption kinetics of high mobility group box 1 protein in a polyacrylonitrile hemofiltration membrane.
    Nakamura T; Moriyama K; Shimomura Y; Kato Y; Kuriyama N; Hara Y; Yamada S; Nishida O
    Ther Apher Dial; 2021 Feb; 25(1):66-72. PubMed ID: 32216030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Superiority of AN69ST Membrane in the Adsorption of Fibroblast Growth Factor-23.
    Minematsu Y; Yamato M; Ikemiya Y; Ito T
    Clin Lab; 2016; 62(1-2):219-25. PubMed ID: 27012053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous renal replacement therapy with a polymethyl methacrylate membrane hemofilter suppresses inflammation in patients after open-heart surgery with cardiopulmonary bypass.
    Mukaida H; Matsushita S; Inotani T; Nakamura A; Amano A
    J Artif Organs; 2018 Jun; 21(2):188-195. PubMed ID: 29404796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of cytokine adsorption properties of polymethyl methacrylate (PMMA) membrane material.
    Kishikawa T; Fujieda H; Sakaguchi H
    J Artif Organs; 2022 Dec; 25(4):343-349. PubMed ID: 35301606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of interleukin-6 removal properties among hemofilters consisting of varying membrane materials and surface areas: an in vitro study.
    Hirayama Y; Oda S; Wakabayashi K; Sadahiro T; Nakamura M; Watanabe E; Tateishi Y
    Blood Purif; 2011; 31(1-3):18-25. PubMed ID: 21135545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
    Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
    Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy between continuous hemodiafiltration with a PMMA high-performance membrane dialyzer and a PAN membrane hemofilter in the treatment of septic shock patients with acute renal failure.
    Matsuda K; Moriguchi T; Harii N; Yanagisawa M; Harada D; Sugawara H
    Contrib Nephrol; 2011; 173():182-190. PubMed ID: 21865791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe sepsis and septic shock by CHDF using a PMMA membrane hemofilter as a cytokine modulator.
    Nakamura M; Oda S; Sadahiro T; Hirayama Y; Watanabe E; Tateishi Y; Nakada TA; Hirasawa H
    Contrib Nephrol; 2010; 166():73-82. PubMed ID: 20472994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.
    Fleming GM; Salama NN; Eid SK; Cooke KR; Mueller BA
    Blood Purif; 2009; 28(4):348-53. PubMed ID: 19729904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.